Tracking Fundamentals
In 2026, the Indian stock market operates at a high velocity. With the RBI maintaining a "sticky" 5% inflation target and the government’s Gati Shakti infrastructure push, tracking fundamentals is no longer just about reading a yearly balance sheet, it’s about monitoring the pulse of a digital-first economy.
Here is the "Continuous Tracking" manual tailored for your Equiscale ecosystem and the Indian market.
1. The Quarterly Ritual: Results Season (NSE/BSE Focus)
Every quarter, Indian companies must report their results within 45 days. In 2026, you must look for the "Indian Alpha" markers:
- KPI Monitoring: For Indian Banks (HDFC, SBI), track the CASA Ratio and Net Interest Margin (NIM). For IT (TCS, Infosys), focus on TCV (Total Contract Value) of AI-specific deals.
- The "Guidance" Check: Management commentary in India is often optimistic. Cross-verify the Management Discussion & Analysis (MD&A) with the actual numbers. If they promised "Double Digit Growth" but delivered 8%, the market will likely punish the P/E multiple.
- Working Capital Watch: In 2026, look for Receivable Days. If a company is selling more but not collecting cash from its Indian distributors, a liquidity crunch is imminent.
2. The 2026 Tracking Toolkit
To stay ahead, you need tools that integrate Corporate Filings with Real-Time Macro Data.
Tool Type | 2026 Recommended Platforms | What to Track in India |
|---|---|---|
All-in-One Academy | Equiscale Academy | Integrated fundamental education, data scraping for Indian firms, and community-driven thesis tracking. |
Financial Portals | Equiscale | 10+ years of historical ratios, "DVM" (Durability, Valuation, Momentum) scores, and custom Excel exports. |
Visual Analysis | Equiscale | "Market Mood Index" (MMI) to gauge retail sentiment and clean visual health checklists. |
Official Filings | NSE India (NEAPS) / SEBI/BSE | Direct access to 10-Qs (Quarterly), 10-Ks (Annual), and "Insider Trading" disclosures. |
Sentiment Analysis | Equiscale | Tracking FII/DII (Foreign/Domestic Institutional Investor) flow and management interview summaries. |
3. Creating a Watchlist & Benchmark
A watchlist in 2026 is your "Waiting Room" for value.
- Define Your Buy Zone: Use the Equiscale valuation models to set a "Trigger Price." In India’s high-growth environment, a 15–20% correction often happens in days; your alerts must be ready.
- Benchmark Against Peers: Don't just track your stock. Track the Nifty Sectoral Index. If you own a pharmaceutical stock growing at 12% while the Nifty Pharma index is growing at 18%, your capital is underperforming.
- Cost of Debt Tracking: As the RBI enters its "shallow easing" phase, track the Interest Coverage Ratio. Companies that replace high-cost 9% debt with 7% debt will see an immediate "Earnings per Share" (EPS) boost.
4. When to "Sell" (The Indian Exit Strategy)
In a market prone to "FOMO" (Fear Of Missing Out), knowing when to sell is your greatest edge.
- The Governance "Smoke": In India, any sudden change in statutory auditors or multiple independent director resignations is a Hard Sell.
- The Payout Trap: If a company starts paying high dividends (Payout > 80%) while its revenue is stagnant, it has run out of growth ideas. In a 2026 "Growth Economy," this is a signal to move your capital elsewhere.
- The Thesis Failure: If your thesis was "Growth via EV integration," but the company’s latest quarterly report shows a pivot back to internal combustion engines (ICE), the "Engine" is no longer what you bought. Sell and move on.
Summary: Your Fundamental Health Check
- Weekly: Check Equiscale for news on sector-specific policy shifts (PLI schemes, RBI circulars).
- Quarterly: Listen to the Earnings Call. Pay attention to the Q&A—this is where the "Promoter’s" confidence is truly tested.
- Annually: Re-verify the Competitive Moat. Has a new AI-native startup disrupted their distribution?